According to Edwards Lifesciences latest financial reports the total debt is $670.00M, an increase of 0.63% to 2022. At the end of 2022 company had $665.80M total debt. This figure represents the debts and financial obligations that Edwards Lifesciences combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $670.00M | 0.63% |
2022 | $665.80M | 0.15% |
2021 | $664.80M | -0.43% |
2020 | $667.70M | 2.20% |
2019 | $653.30M | 10.02% |
2018 | $593.80M | - |